Man Group plc Purchases Shares of 90,235 CME Group Inc. $CME

Key Points

• Man Group acquired 90,235 CME Group shares during the second quarter, valued at approximately $19.9 million. Institutional investors collectively own 87.75% of CME’s stock.
• CME Group exceeded quarterly earnings expectations, reporting $2.99 in EPS and $1.71 billion in revenue, while analysts maintain a consensus “Hold” rating with a $288.56 price target.
• The company declared a quarterly dividend of $1.30 per share, or $5.20 annualized, representing a 1.9% yield and a 44.11% payout ratio.

Man Group plc acquired a new position in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 90,235 shares of the financial services provider's stock, valued at approximately $19,927,000.

A number of other large investors have also recently made changes to their positions in CME. Whipplewood Advisors LLC increased its position in shares of CME Group by 2,075.0% during the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider's stock worth $26,000 after acquiring an additional 83 shares in the last quarter. Elkhorn Partners Limited Partnership bought a new position in CME Group in the 4th quarter valued at about $27,000. Hilton Head Capital Partners LLC acquired a new position in CME Group during the 4th quarter valued at about $28,000. Mowery & Schoenfeld Wealth Management LLC acquired a new position in CME Group during the 2nd quarter valued at about $28,000. Finally, Legacy Wealth Managment LLC ID increased its holdings in CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider's stock worth $29,000 after purchasing an additional 71 shares in the last quarter. 87.75% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the company. Raymond James Financial reissued an "outperform" rating and issued a $320.00 price objective on shares of CME Group in a research note on Thursday, July 2nd. UBS Group cut their target price on CME Group from $310.00 to $260.00 and set a "buy" rating on the stock in a research report on Monday, July 6th. Morgan Stanley upped their price target on CME Group from $324.00 to $330.00 and gave the stock an "overweight" rating in a report on Thursday, July 23rd. Erste Group Bank lowered CME Group from a "buy" rating to a "hold" rating in a research report on Friday, June 5th. Finally, Wall Street Zen cut CME Group from a "sell" rating to a "strong sell" rating in a research note on Saturday, August 1st. Nine investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company's stock. According to MarketBeat.com, CME Group has a consensus rating of "Hold" and a consensus price target of $288.56.

Insider Buying and Selling

In other CME Group news, Director William R. Shepard acquired 325 shares of the business's stock in a transaction on Thursday, June 25th. The shares were acquired at an average price of $230.57 per share, with a total value of $74,935.25. Following the completion of the transaction, the director owned 260,442 shares in the company, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 0.30% of the company's stock.

CME Group Trading Up 1.3%

Shares of CME stock opened at $280.98 on Thursday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market capitalization of $101.03 billion, a price-to-earnings ratio of 23.83, a PEG ratio of 3.30 and a beta of 0.23. CME Group Inc. has a 52-week low of $218.31 and a 52-week high of $329.16. The company has a 50-day simple moving average of $252.32 and a two-hundred day simple moving average of $279.24.

CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping the consensus estimate of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The firm had revenue of $1.71 billion for the quarter, compared to analysts' expectations of $1.68 billion. During the same quarter last year, the firm earned $2.96 EPS. The company's quarterly revenue was up .8% compared to the same quarter last year. Research analysts anticipate that CME Group Inc. will post 12.27 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group's dividend payout ratio (DPR) is presently 44.11%.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source